Disease Stability in Segmental and Non-Segmental Vitiligo
Overview
Affiliations
Introduction: Some therapeutic decisions in vitiligo depend on the likelihood of the disease remaining stable and inactive.
Aim: To determine a period of disease stability in vitiligo following which reactivation was unlikely.
Materials And Methods: This cross-sectional descriptive study was carried out in 200 patients where a detailed clinical history of the disease activity and stability over the course of vitiligo was recorded.
Results: There were 167 (83.5%) patients with non-segmental vitiligo and 33 (16.5%) with segmental vitiligo. For every 1-year increase in the duration of the disease, stable and active periods increased by 0.7 and 0.3 years, respectively in non-segmental vitiligo and by 0.9 and 0.1 years in segmental vitiligo ( < 0.01). When segmental vitiligo was stable for at least 2 years, it was five times less likely to re-activate than the disease that was stable for less than 2 years ( = 0.16). However, in non-segmental vitiligo, we found no association between the duration of stability and risk of reactivation.
Conclusions: Segmental vitiligo usually becomes inactive after the disease has been stable for 2 years. Non-segmental vitiligo is prone to reactivation even after prolonged periods of stability.
Vitiligo and the microbiome of the gut and skin: a systematic review.
Nigro A, Osman A, Suryadevara P, Cices A Arch Dermatol Res. 2025; 317(1):201.
PMID: 39777551 DOI: 10.1007/s00403-024-03679-6.
Du Z, Wang H, Gao Y, Zheng S, Kou X, Sun G Clin Cosmet Investig Dermatol. 2023; 16:821-836.
PMID: 37033783 PMC: 10075956. DOI: 10.2147/CCID.S403732.
Management of Stable Vitiligo-A Review of the Surgical Approach.
Grochocka M, Welniak A, Bialczyk A, Marek-Jozefowicz L, Tadrowski T, Czajkowski R J Clin Med. 2023; 12(5).
PMID: 36902772 PMC: 10004352. DOI: 10.3390/jcm12051984.